Feed BON
BO

Bon Natural Life Limited

BON · NASDAQ

$1.11 +0.03% (+$0.00)
1M -2.63%
Market Cap $6.76M
P/E Ratio -
Div. Yield -
ROE 4.16%

Bulios Fair Price

$1.44

29.7% upside

Current Price

$1.11

Undervalued Fair Value Overvalued

According to Bulios Fair Price, BON is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Weak
1/9
Valuation
100 /100
Cheap
P/B 0.12x
P/S 0.36x
EV/FFO N/A
Growth
22 /100
Declining
Book val. growth 24.86%
Rev. growth 14.54%
FCF growth N/A
Profitability
12 /100
Weak
Op. margin 8.69%
Gross margin 20.77%
FCF margin 22.66%
Quality
2 /100
Poor
ROA 2.34%
ROIC 2.77%
Asset turnover 0.22x
Debt
66 /100
Moderate
Int. coverage -3.67x
Debt/Equity 0.21x
Current ratio 1.74x
Stability
45 /100
Moderate
EPS volatility 266.12%
Beta -0.25x
Profitable years 0

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about BON
Online

About the company

Bon Natural Life Limited (BON) is a Hong Kong-based company specializing in the production and distribution of natural food products and dietary supplements. With a presence in the realm of healthy eating and wellness, Bon Natural Life is a key player in the world of natural food products. Their offerings encompass various types of food products, including organic foods, dietary supplements, and products promoting a healthy lifestyle. The company focuses on providing quality products with natural ingredients and without artificial additives. Bon Natural Life aims to promote a healthy lifestyle and overall well-being of its customers. Bon Natural Life Limited (BON) shares could be suitable for investors looking to invest in the natural food products and wellness sector with a company emphasizing quality and a healthy lifestyle.

Sector

Basic Materials

Industry

Chemicals - Specialty

CEO

Yongwei Hu

Employees

96

Headquarters

Xi'an

Upcoming events

02 DEC

Earnings

Upcoming earnings report

79d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.